Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats
These medications were initially developed for type 2 diabetes, and more recently have been approved for weight management, because they can reduce appetite, slow gastric emptying, and improve insulin sensitivity
In addition, lifestyle factors can play an important role in skin aging and health in general
Center S, Harte J, Watrous D, et al
The NDC is a universal number that identifies a drug or a related drug item
Significant correlations of dermal total carotenoids and dermal lycopene with their respective plasma levels in healthy adults